The European Medicines Agency's Veterinary Medicines Division is responsible for all activities related to veterinary medicines for which the Agency is responsible. This includes the provision of advice during the development of products, the authorisation process itself and post-authorisation activities such as variations to authorisations and pharmacovigilance, as well as all aspects of public health related to the use of veterinary medicines, particularly the establishment of maximum residue levels (MRLs) for the presence of residues of veterinary medicines in foodstuffs of animal origin.
The Division provides the secretariat to the Committee for Medicinal Products for Veterinary Use (CVMP), Coordination Group for Mutual Recognition and Decentralised Procedures - Veterinary (CMDv) and working parties that support the work of the Agency on veterinary medicines, and contributes to those activities of the Agency that span both human and veterinary activities, in line with the 'one health' approach.
The Division acts as the source of advice from the Agency on veterinary topics to European Union institutions, the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) and international organisations such as the World Organisation for Animal Health (OIE) and Codex Alimentarius.
An organisation chart below shows the full structure of the Veterinary Medicines Division.